Genome-wide CRISPR Screening Identifies NFκB and c-MET as Druggable Targets to Sensitize Lenvatinib Treatment in Hepatocellular Carcinoma.
全基因组 CRISPR 筛选发现 NFβ 和 c-MET 是可药物靶点，可增强 Lenvatinib 对肝细胞癌的治疗效果
期刊:Cellular and Molecular Gastroenterology and Hepatology
影响因子:7.4
doi:10.1016/j.jcmgh.2025.101502
Wan Ting-Chi Rebecca, Wei Lai, Cheng Lai-Hung, Chin Wai-Ching, Shen Jialing, Chan For-Fan, Kuang Zhijian, Wang Cun, Wong Carmen Chak-Lui, Wong Chun-Ming
